Sort
64,565 grants matching “drug discovery”
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$968,937William C Hahn · Dana-Farber Cancer Inst · U01 · FY2019 · CA
Connectivity Map 100k
$968,711Todd R. Golub · Broad Institute, Inc. · RC2 · FY2010 · HG
Transporter Elucidation Center at the University of California, San Francisco
$968,661Kathleen M Giacomini · University Of California, San Francisco · UC2 · FY2025 · HD
Characterization of the Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of a Candidate HIV Prevention Drug in Rhesus Macaques
$968,613Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2022 · AI
Robust Predictor of Colon Cancer Risk
$968,518Harry Ostrer · Morgan And Mendel Genomics, Inc. · R42 · FY2022 · CA
POP: 2/22/17-2/21/21. PRECLINICAL MEDICATIONS DISCOVERY AND ABUSE LIABILITY TESTING FOR NIDA. N01DA-17-8932. PURPOSE: TO EXERCISE OPTION QUANTITY 1(CO
$968,474Patrick Beardsley · Virginia Commonwealth University · N01 · FY2020 · DA
Disease Modifying Biologics for Rheumatoid Arthritis
$968,470Rekha Bansal · Novelmed Therapeutics, Inc. · R44 · FY2012 · AG
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine
$968,360Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2024 · AI
Immobilized Receptors In Drug Discovery
$968,328Irving William Wainer · National Institute On Aging · ZIA · FY2012 · AG
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$968,250Claire F Verschraegen · Ohio State University · UG1 · FY2023 · CA
Cannabinoid CB1 and CB2 receptors and drug abuse
$968,160Zheng-Xiong Xi · National Institute On Drug Abuse · ZIG · FY2022 · DA
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine
$968,151Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2023 · AI
Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD
$967,956William C Raschke · Virogenics, Inc. · R44 · FY2019 · AI
Informatics Tools for High-Throughput Sequences Data Analysis
$967,608Eric Banks · Broad Institute, Inc. · U01 · FY2015 · HG
Rapid-Response Crystallography
$967,605Marc Allaire · University Of Calif-Lawrenc Berkeley Lab · P30 · FY2023 · GM
Connectivity Map 100k
$967,265Todd R. Golub · Broad Institute, Inc. · RC2 · FY2009 · HG
Development of a Commercial Platform for Discovery and Validation of Key Microbial Metabolites in CNS Disorders
$967,251Todd Z Desantis · Second Genome, Inc. · R44 · FY2020 · DA
Biostatistics Resource
$967,148Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2009 · CA
Developmental Funds
$967,046Stanton L Gerson · Case Western Reserve University · P30 · FY2019 · CA
Identifying and targeting collateral lethal vulnerabilities in cancers
$967,038Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
Identifying and targeting collateral lethal vulnerabilities in cancers
$967,038Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
Hybrid Molecules Designed to Enhance Antibiotic Activity
$967,036George E Wright · Glsynthesis, Inc. · R44 · FY2008 · AI
Active Immunization for Treating Methamphetamine Abuse
$966,958S. Michael Owens · Univ Of Arkansas For Med Scis · U01 · FY2010 · DA
Wisconsin and New Jersey Alliance in Precision Experimental Therapeutics
$966,949Salma Jabbour · Rbhs -Cancer Institute Of New Jersey · UM1 · FY2019 · CA
A Web Service for Fragment-based Selectivity Analysis of Drug Leads
$966,453John Laurence Kulp III · Conifer Point Pharmaceuticals, Llc · R44 · FY2023 · GM